Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-14

Clinical Trial Update: Major Depressive Disorder With Mixed Features - Extension [Phase 3]

View source ↗

Summary

Extension of a Phase 3 trial in major depressive disorder with mixed features; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-10-14